|Molly Thompson

About Molly Thompson

This author has not yet filled in any details.
So far Molly Thompson has created 16 blog entries.
2nd Aug, 2017

Press Release: Firma provides support associated with FDA approval of Baxdela™

2017-12-08T19:38:58+00:00August 2nd, 2017|Categories: News & Media|Tags: |

Firma Clinical Research, an ISO quality management-certified clinical research organization (CRO), is pleased to announce its contribution to the FDA approval of Melinta Therapeutics’ lead antibiotic, Baxdela™ (delafloxacin), for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria.